Skip to main content
NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
3.000
-0.060 (-1.96%)
Apr 26, 2024, 11:35 AM EDT - Market open

NeuroBo Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for NRBO.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for NRBO.

Recommendation Trends

Rating Sep '22Oct '22Nov '22Dec '22
Strong Buy 1110
Buy 0000
Hold 0000
Sell 0000
Strong Sell 0000
Total 1110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Aydin Huseynov
Ladenburg Thalmann
 Ladenburg Thalmann
Strong Buy
Initiates
$48
 Strong Buy Initiates $48 +1,500.00% Dec 7, 2022
Raghuram Selvaraju
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Maintains
$4,800 → $3,840
 Strong Buy Maintains $4,800 → $3,840 +127,900.00% Feb 1, 2021
Raghuram Selvaraju
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Initiates
$4,800
 Strong Buy Initiates $4,800 +159,900.00% Jun 15, 2020
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.32
from -2.46
EPS Next Year
-2.54
from -3.32
Year 20192020202120222023202420252026
Revenue
--------
Revenue Growth
--------
EPS
-979.30-439.24-158.48-43.42-2.46-3.32-2.54-2.63
EPS Growth
--------
No. Analysts -----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -2.97 -2.04 -2.71
Avg -3.32 -2.54 -2.63
Low -3.61 -2.98 -2.53

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.